Top Links

Articles Related to SCT

Treosulfan Plus Fludarabine – Encouraging Conditioning for Allogeneic Hematopoietic Stem Cell Transplantation in Multiple Myeloma

Allogeneic transplantation (Allo-SCT) in multiple myeloma is controversial mainly due to the relatively high non-relapse mortality (NRM). The aim with this retrospective single-center study was to evaluate recent transplants particularly after conditioning with treosulfan plus fludarabine (TreoFlu).
View complete article: PDF  |  Full-text

Responses and Survival under Pegylated Interferon α2a Treatment for Patients with Post-MPN Acute Myeloid Leukemia and Acute Panmyelosis with Myelofibrosis

We report here for the first time the efficacy of pegylated interferon α2a (Peg-Ifn) as a therapy for patients with myelofibrosis and high blast counts. We treated four patients who were in an accelerated phase of myeloproliferative neoplasms or acute panmyelosis with myelofibrosis using only this drug.
View complete article: PDF  |  Full-text

Effects of Age and Sex on Sickle Cell Disease Avascular Necrosis

Sickle cell disease (SCD) is a hemoglobinopathy. Based on genotypes, it is classified into sickle cell thalassemia (SCTh) and sickle cell anemia (SCA).
View complete article: PDF  |  Full-text

Mesenchymal Stem Cells from Different Tissues: Immune Status and Activity

Mesenchymal stem cells (MSCs) have been found in almost all tissues and due to their regenerative properties represent promising tools in cell-based therapy. Role of MSCs in tissue repair is strongly governed by their interplay with immune cells and regulating factors.
View complete article: PDF  |  Full-text

Sacrococcygeal Teratoma in a Developing Community

An epidemiologic data pool was formed from cases of SCT submitted as surgical specimens to a Reference Pathology Laboratory serving the Igbo Ethnic Group in South-Eastern Nigeria.
View complete article: PDF  |  Full-text


Editorial Board Members Related to SCT

Massimo Dominici

Assistant Professor
Head Laboratory of Cell Biology and Advanced Cancer Therapies
Department of Medical and Surgical Sciences for Children & Adults
University Hospital of Modena and Reggio Emilia
Italy

Eva Mischak-Weissinger

Professor
Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation
Hannover Medical School
Germany
Submit Manuscript